Aperio Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $271K | Buy |
12,801
+1,244
| +11% | +$26.3K | ﹤0.01% | 2221 |
|
|
2020
Q3 | $171K | Buy |
+11,557
| New | +$171K | ﹤0.01% | 2257 |
|
|
2020
Q1 | – | Sell |
-9,933
| Closed | -$233K | – | 2370 |
|
|
2019
Q4 | $233K | Buy |
+9,933
| New | +$233K | ﹤0.01% | 2149 |
|
|
2019
Q3 | – | Sell |
-8,205
| Closed | -$153K | – | 2513 |
|
|
2019
Q2 | $153K | Sell |
8,205
-1,584
| -16% | -$29.5K | ﹤0.01% | 2265 |
|
|
2019
Q1 | $239K | Sell |
9,789
-2,096
| -18% | -$51.2K | ﹤0.01% | 2094 |
|
|
2018
Q4 | $308K | Sell |
11,885
-1,828
| -13% | -$47.4K | ﹤0.01% | 1928 |
|
|
2018
Q3 | $434K | Buy |
13,713
+2,452
| +22% | +$77.6K | ﹤0.01% | 1842 |
|
|
2018
Q2 | $437K | Buy |
11,261
+1,416
| +14% | +$55K | ﹤0.01% | 1807 |
|
|
2018
Q1 | $272K | Buy |
+9,845
| New | +$272K | ﹤0.01% | 1997 |
|